Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-02-27 @ 4:56 AM
Study NCT ID:
NCT02835534
Status:
COMPLETED
Last Update Posted:
2022-05-25
First Post:
2016-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
Sponsor:
CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CP-2015-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None